nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R1—hematologic cancer	0.429	1	CbGaD
Isoprenaline—L-DOPA—Melphalan—hematologic cancer	0.11	1	CrCrCtD
Isoprenaline—CYP1A1—Methoxsalen—hematologic cancer	0.0275	0.191	CbGbCtD
Isoprenaline—CYP1A1—Bortezomib—hematologic cancer	0.0262	0.181	CbGbCtD
Isoprenaline—CYP1A1—Daunorubicin—hematologic cancer	0.025	0.173	CbGbCtD
Isoprenaline—CYP1A1—Thalidomide—hematologic cancer	0.0228	0.158	CbGbCtD
Isoprenaline—CYP1A1—Dacarbazine—hematologic cancer	0.0196	0.136	CbGbCtD
Isoprenaline—CYP1A1—Dasatinib—hematologic cancer	0.0154	0.107	CbGbCtD
Isoprenaline—CYP1A1—Dexamethasone—hematologic cancer	0.00789	0.0546	CbGbCtD
Isoprenaline—PIK3R3—gonad—hematologic cancer	0.00266	0.0714	CbGeAlD
Isoprenaline—ADRBK1—hematopoietic system—hematologic cancer	0.00207	0.0555	CbGeAlD
Isoprenaline—MAPK1—hematopoietic system—hematologic cancer	0.00204	0.0547	CbGeAlD
Isoprenaline—PIK3R3—lung—hematologic cancer	0.00203	0.0545	CbGeAlD
Isoprenaline—PIK3R1—blood—hematologic cancer	0.00198	0.0531	CbGeAlD
Isoprenaline—PIK3R3—testis—hematologic cancer	0.00192	0.0514	CbGeAlD
Isoprenaline—PIK3R1—bone marrow—hematologic cancer	0.00192	0.0514	CbGeAlD
Isoprenaline—PIK3R1—lung—hematologic cancer	0.00174	0.0466	CbGeAlD
Isoprenaline—PIK3R1—testis—hematologic cancer	0.00164	0.0439	CbGeAlD
Isoprenaline—ADRBK1—gonad—hematologic cancer	0.00157	0.0422	CbGeAlD
Isoprenaline—MAPK1—gonad—hematologic cancer	0.00155	0.0416	CbGeAlD
Isoprenaline—PIK3R3—lymph node—hematologic cancer	0.00139	0.0373	CbGeAlD
Isoprenaline—ADRBK1—blood—hematologic cancer	0.00137	0.0367	CbGeAlD
Isoprenaline—MAPK1—blood—hematologic cancer	0.00135	0.0362	CbGeAlD
Isoprenaline—ADRBK1—bone marrow—hematologic cancer	0.00133	0.0356	CbGeAlD
Isoprenaline—MAPK1—bone marrow—hematologic cancer	0.00131	0.035	CbGeAlD
Isoprenaline—ADRBK1—lung—hematologic cancer	0.0012	0.0322	CbGeAlD
Isoprenaline—PIK3R1—lymph node—hematologic cancer	0.00119	0.0318	CbGeAlD
Isoprenaline—MAPK1—lung—hematologic cancer	0.00118	0.0317	CbGeAlD
Isoprenaline—ADRBK1—testis—hematologic cancer	0.00113	0.0304	CbGeAlD
Isoprenaline—MAPK1—testis—hematologic cancer	0.00112	0.03	CbGeAlD
Isoprenaline—L-DOPA—PSIP1—hematologic cancer	0.00105	0.553	CrCbGaD
Isoprenaline—ADRBK1—lymph node—hematologic cancer	0.000821	0.022	CbGeAlD
Isoprenaline—MAPK1—lymph node—hematologic cancer	0.000809	0.0217	CbGeAlD
Isoprenaline—CYP1A1—hematopoietic system—hematologic cancer	0.000558	0.015	CbGeAlD
Isoprenaline—ADRB1—lung—hematologic cancer	0.000502	0.0135	CbGeAlD
Isoprenaline—Masoprocol—ALOX5—hematologic cancer	0.000397	0.209	CrCbGaD
Isoprenaline—CYP1A1—blood—hematologic cancer	0.00037	0.00992	CbGeAlD
Isoprenaline—CYP1A1—lung—hematologic cancer	0.000324	0.00869	CbGeAlD
Isoprenaline—CYP1A1—lymph node—hematologic cancer	0.000222	0.00594	CbGeAlD
Isoprenaline—Norepinephrine—SLC22A1—hematologic cancer	0.00013	0.0683	CrCbGaD
Isoprenaline—Dopamine—SLC22A1—hematologic cancer	0.000121	0.0635	CrCbGaD
Isoprenaline—Epinephrine—SLC22A1—hematologic cancer	0.000118	0.062	CrCbGaD
Isoprenaline—Convulsion—Vincristine—hematologic cancer	9.98e-05	0.00108	CcSEcCtD
Isoprenaline—Flushing—Etoposide—hematologic cancer	9.95e-05	0.00108	CcSEcCtD
Isoprenaline—Hypertension—Vincristine—hematologic cancer	9.95e-05	0.00108	CcSEcCtD
Isoprenaline—Hyperhidrosis—Thalidomide—hematologic cancer	9.92e-05	0.00107	CcSEcCtD
Isoprenaline—Dyspnoea—Vinorelbine—hematologic cancer	9.9e-05	0.00107	CcSEcCtD
Isoprenaline—Headache—Procarbazine—hematologic cancer	9.86e-05	0.00107	CcSEcCtD
Isoprenaline—Pulmonary oedema—Doxorubicin—hematologic cancer	9.86e-05	0.00107	CcSEcCtD
Isoprenaline—Convulsion—Mitoxantrone—hematologic cancer	9.72e-05	0.00105	CcSEcCtD
Isoprenaline—Hypertension—Mitoxantrone—hematologic cancer	9.69e-05	0.00105	CcSEcCtD
Isoprenaline—Hypertension—Irinotecan—hematologic cancer	9.69e-05	0.00105	CcSEcCtD
Isoprenaline—Headache—Dasatinib—hematologic cancer	9.67e-05	0.00105	CcSEcCtD
Isoprenaline—Headache—Bexarotene—hematologic cancer	9.67e-05	0.00105	CcSEcCtD
Isoprenaline—Headache—Fludarabine—hematologic cancer	9.64e-05	0.00104	CcSEcCtD
Isoprenaline—Nausea—Busulfan—hematologic cancer	9.64e-05	0.00104	CcSEcCtD
Isoprenaline—Tachycardia—Carmustine—hematologic cancer	9.61e-05	0.00104	CcSEcCtD
Isoprenaline—Vision blurred—Cisplatin—hematologic cancer	9.6e-05	0.00104	CcSEcCtD
Isoprenaline—Asthenia—Vinblastine—hematologic cancer	9.59e-05	0.00104	CcSEcCtD
Isoprenaline—Hypotension—Thalidomide—hematologic cancer	9.58e-05	0.00104	CcSEcCtD
Isoprenaline—Tremor—Cisplatin—hematologic cancer	9.55e-05	0.00103	CcSEcCtD
Isoprenaline—Tachycardia—Alitretinoin—hematologic cancer	9.52e-05	0.00103	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisolone—hematologic cancer	9.45e-05	0.00102	CcSEcCtD
Isoprenaline—Hypertension—Gemcitabine—hematologic cancer	9.44e-05	0.00102	CcSEcCtD
Isoprenaline—Hyperhidrosis—Alitretinoin—hematologic cancer	9.43e-05	0.00102	CcSEcCtD
Isoprenaline—Dizziness—Nilotinib—hematologic cancer	9.43e-05	0.00102	CcSEcCtD
Isoprenaline—Dizziness—Imatinib—hematologic cancer	9.38e-05	0.00101	CcSEcCtD
Isoprenaline—Nausea—Procarbazine—hematologic cancer	9.35e-05	0.00101	CcSEcCtD
Isoprenaline—Hyperhidrosis—Ifosfamide—hematologic cancer	9.32e-05	0.00101	CcSEcCtD
Isoprenaline—Insomnia—Thalidomide—hematologic cancer	9.28e-05	0.001	CcSEcCtD
Isoprenaline—Dizziness—Cladribine—hematologic cancer	9.21e-05	0.000996	CcSEcCtD
Isoprenaline—Hypotension—Carmustine—hematologic cancer	9.2e-05	0.000995	CcSEcCtD
Isoprenaline—Nausea—Dasatinib—hematologic cancer	9.17e-05	0.000991	CcSEcCtD
Isoprenaline—Nausea—Bexarotene—hematologic cancer	9.17e-05	0.000991	CcSEcCtD
Isoprenaline—Dyspnoea—Thalidomide—hematologic cancer	9.14e-05	0.000989	CcSEcCtD
Isoprenaline—Nausea—Fludarabine—hematologic cancer	9.14e-05	0.000988	CcSEcCtD
Isoprenaline—Asthenia—Melphalan—hematologic cancer	9.12e-05	0.000986	CcSEcCtD
Isoprenaline—Hypotension—Alitretinoin—hematologic cancer	9.12e-05	0.000986	CcSEcCtD
Isoprenaline—Hyperhidrosis—Vincristine—hematologic cancer	9.09e-05	0.000983	CcSEcCtD
Isoprenaline—Hypotension—Ifosfamide—hematologic cancer	9.01e-05	0.000974	CcSEcCtD
Isoprenaline—Tachycardia—Mitoxantrone—hematologic cancer	8.94e-05	0.000966	CcSEcCtD
Isoprenaline—Headache—Nilotinib—hematologic cancer	8.93e-05	0.000966	CcSEcCtD
Isoprenaline—Insomnia—Carmustine—hematologic cancer	8.91e-05	0.000963	CcSEcCtD
Isoprenaline—Headache—Imatinib—hematologic cancer	8.88e-05	0.00096	CcSEcCtD
Isoprenaline—Asthenia—Lenalidomide—hematologic cancer	8.87e-05	0.000959	CcSEcCtD
Isoprenaline—Hyperhidrosis—Irinotecan—hematologic cancer	8.85e-05	0.000957	CcSEcCtD
Isoprenaline—Hyperhidrosis—Mitoxantrone—hematologic cancer	8.85e-05	0.000957	CcSEcCtD
Isoprenaline—Dizziness—Vinblastine—hematologic cancer	8.84e-05	0.000955	CcSEcCtD
Isoprenaline—Convulsion—Cisplatin—hematologic cancer	8.83e-05	0.000954	CcSEcCtD
Isoprenaline—Insomnia—Alitretinoin—hematologic cancer	8.83e-05	0.000954	CcSEcCtD
Isoprenaline—Hypotension—Vincristine—hematologic cancer	8.79e-05	0.00095	CcSEcCtD
Isoprenaline—Dyspnoea—Carmustine—hematologic cancer	8.78e-05	0.000949	CcSEcCtD
Isoprenaline—Asthenia—Hydroxyurea—hematologic cancer	8.74e-05	0.000945	CcSEcCtD
Isoprenaline—Headache—Cladribine—hematologic cancer	8.73e-05	0.000944	CcSEcCtD
Isoprenaline—Dyspnoea—Alitretinoin—hematologic cancer	8.7e-05	0.000941	CcSEcCtD
Isoprenaline—Arrhythmia—Triamcinolone—hematologic cancer	8.69e-05	0.000939	CcSEcCtD
Isoprenaline—Vision blurred—Prednisolone—hematologic cancer	8.68e-05	0.000938	CcSEcCtD
Isoprenaline—Nausea—Chlorambucil—hematologic cancer	8.66e-05	0.000936	CcSEcCtD
Isoprenaline—Hyperhidrosis—Gemcitabine—hematologic cancer	8.62e-05	0.000932	CcSEcCtD
Isoprenaline—Dyspnoea—Ifosfamide—hematologic cancer	8.6e-05	0.00093	CcSEcCtD
Isoprenaline—Hypotension—Mitoxantrone—hematologic cancer	8.56e-05	0.000925	CcSEcCtD
Isoprenaline—Hypotension—Irinotecan—hematologic cancer	8.56e-05	0.000925	CcSEcCtD
Isoprenaline—Insomnia—Vincristine—hematologic cancer	8.51e-05	0.00092	CcSEcCtD
Isoprenaline—Epinephrine—TNF—hematologic cancer	8.49e-05	0.0446	CrCbGaD
Isoprenaline—Nausea—Nilotinib—hematologic cancer	8.47e-05	0.000916	CcSEcCtD
Isoprenaline—Nausea—Imatinib—hematologic cancer	8.42e-05	0.000911	CcSEcCtD
Isoprenaline—Vertigo—Etoposide—hematologic cancer	8.39e-05	0.000907	CcSEcCtD
Isoprenaline—Headache—Vinblastine—hematologic cancer	8.37e-05	0.000905	CcSEcCtD
Isoprenaline—Hypotension—Gemcitabine—hematologic cancer	8.34e-05	0.000901	CcSEcCtD
Isoprenaline—Insomnia—Irinotecan—hematologic cancer	8.28e-05	0.000895	CcSEcCtD
Isoprenaline—Nausea—Cladribine—hematologic cancer	8.28e-05	0.000895	CcSEcCtD
Isoprenaline—Vertigo—Prednisolone—hematologic cancer	8.27e-05	0.000894	CcSEcCtD
Isoprenaline—Cardiac arrest—Epirubicin—hematologic cancer	8.26e-05	0.000893	CcSEcCtD
Isoprenaline—Dizziness—Lenalidomide—hematologic cancer	8.17e-05	0.000884	CcSEcCtD
Isoprenaline—Dyspnoea—Irinotecan—hematologic cancer	8.16e-05	0.000883	CcSEcCtD
Isoprenaline—Dyspnoea—Mitoxantrone—hematologic cancer	8.16e-05	0.000883	CcSEcCtD
Isoprenaline—Asthenia—Bortezomib—hematologic cancer	8.16e-05	0.000882	CcSEcCtD
Isoprenaline—Tachycardia—Cisplatin—hematologic cancer	8.12e-05	0.000877	CcSEcCtD
Isoprenaline—Asthenia—Bleomycin—hematologic cancer	8.1e-05	0.000875	CcSEcCtD
Isoprenaline—Convulsion—Etoposide—hematologic cancer	8.09e-05	0.000874	CcSEcCtD
Isoprenaline—Insomnia—Gemcitabine—hematologic cancer	8.07e-05	0.000872	CcSEcCtD
Isoprenaline—Hypertension—Etoposide—hematologic cancer	8.06e-05	0.000871	CcSEcCtD
Isoprenaline—Dizziness—Hydroxyurea—hematologic cancer	8.06e-05	0.000871	CcSEcCtD
Isoprenaline—Hyperhidrosis—Cisplatin—hematologic cancer	8.04e-05	0.000869	CcSEcCtD
Isoprenaline—Convulsion—Prednisolone—hematologic cancer	7.98e-05	0.000862	CcSEcCtD
Isoprenaline—Asthenia—Vinorelbine—hematologic cancer	7.97e-05	0.000861	CcSEcCtD
Isoprenaline—Dyspnoea—Gemcitabine—hematologic cancer	7.95e-05	0.00086	CcSEcCtD
Isoprenaline—Hypertension—Prednisolone—hematologic cancer	7.95e-05	0.000859	CcSEcCtD
Isoprenaline—Nausea—Vinblastine—hematologic cancer	7.94e-05	0.000858	CcSEcCtD
Isoprenaline—Arrhythmia—Dexamethasone—hematologic cancer	7.88e-05	0.000852	CcSEcCtD
Isoprenaline—Arrhythmia—Betamethasone—hematologic cancer	7.88e-05	0.000852	CcSEcCtD
Isoprenaline—Hypotension—Cisplatin—hematologic cancer	7.77e-05	0.00084	CcSEcCtD
Isoprenaline—Headache—Lenalidomide—hematologic cancer	7.74e-05	0.000837	CcSEcCtD
Isoprenaline—Cardiac arrest—Doxorubicin—hematologic cancer	7.64e-05	0.000826	CcSEcCtD
Isoprenaline—Headache—Hydroxyurea—hematologic cancer	7.63e-05	0.000825	CcSEcCtD
Isoprenaline—Asthenia—Thiotepa—hematologic cancer	7.61e-05	0.000823	CcSEcCtD
Isoprenaline—Vertigo—Triamcinolone—hematologic cancer	7.61e-05	0.000822	CcSEcCtD
Isoprenaline—Nausea—Melphalan—hematologic cancer	7.55e-05	0.000816	CcSEcCtD
Isoprenaline—Dizziness—Bortezomib—hematologic cancer	7.52e-05	0.000813	CcSEcCtD
Isoprenaline—Tachycardia—Etoposide—hematologic cancer	7.43e-05	0.000804	CcSEcCtD
Isoprenaline—Dyspnoea—Cisplatin—hematologic cancer	7.41e-05	0.000801	CcSEcCtD
Isoprenaline—Hyperhidrosis—Etoposide—hematologic cancer	7.36e-05	0.000796	CcSEcCtD
Isoprenaline—Asthenia—Thalidomide—hematologic cancer	7.36e-05	0.000796	CcSEcCtD
Isoprenaline—Dizziness—Vinorelbine—hematologic cancer	7.34e-05	0.000794	CcSEcCtD
Isoprenaline—Nausea—Lenalidomide—hematologic cancer	7.34e-05	0.000794	CcSEcCtD
Isoprenaline—Convulsion—Triamcinolone—hematologic cancer	7.34e-05	0.000793	CcSEcCtD
Isoprenaline—Tachycardia—Prednisolone—hematologic cancer	7.33e-05	0.000793	CcSEcCtD
Isoprenaline—Angina pectoris—Epirubicin—hematologic cancer	7.31e-05	0.000791	CcSEcCtD
Isoprenaline—Hypertension—Triamcinolone—hematologic cancer	7.31e-05	0.00079	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisolone—hematologic cancer	7.26e-05	0.000785	CcSEcCtD
Isoprenaline—Nausea—Hydroxyurea—hematologic cancer	7.24e-05	0.000783	CcSEcCtD
Isoprenaline—Flushing—Prednisone—hematologic cancer	7.13e-05	0.000771	CcSEcCtD
Isoprenaline—Headache—Bortezomib—hematologic cancer	7.12e-05	0.00077	CcSEcCtD
Isoprenaline—Hypotension—Etoposide—hematologic cancer	7.12e-05	0.00077	CcSEcCtD
Isoprenaline—Asthenia—Carmustine—hematologic cancer	7.07e-05	0.000764	CcSEcCtD
Isoprenaline—Dizziness—Thiotepa—hematologic cancer	7.01e-05	0.000758	CcSEcCtD
Isoprenaline—Asthenia—Alitretinoin—hematologic cancer	7e-05	0.000757	CcSEcCtD
Isoprenaline—Headache—Vinorelbine—hematologic cancer	6.96e-05	0.000752	CcSEcCtD
Isoprenaline—Asthenia—Ifosfamide—hematologic cancer	6.92e-05	0.000748	CcSEcCtD
Isoprenaline—Vertigo—Betamethasone—hematologic cancer	6.9e-05	0.000746	CcSEcCtD
Isoprenaline—Vertigo—Dexamethasone—hematologic cancer	6.9e-05	0.000746	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—hematologic cancer	6.86e-05	0.000742	CcSEcCtD
Isoprenaline—Sweating—Methotrexate—hematologic cancer	6.86e-05	0.000742	CcSEcCtD
Isoprenaline—Insomnia—Prednisolone—hematologic cancer	6.8e-05	0.000735	CcSEcCtD
Isoprenaline—Dyspnoea—Etoposide—hematologic cancer	6.79e-05	0.000734	CcSEcCtD
Isoprenaline—Dizziness—Thalidomide—hematologic cancer	6.78e-05	0.000733	CcSEcCtD
Isoprenaline—Angina pectoris—Doxorubicin—hematologic cancer	6.77e-05	0.000732	CcSEcCtD
Isoprenaline—Nausea—Bortezomib—hematologic cancer	6.76e-05	0.00073	CcSEcCtD
Isoprenaline—Asthenia—Vincristine—hematologic cancer	6.75e-05	0.000729	CcSEcCtD
Isoprenaline—Tachycardia—Triamcinolone—hematologic cancer	6.74e-05	0.000729	CcSEcCtD
Isoprenaline—Nausea—Bleomycin—hematologic cancer	6.7e-05	0.000725	CcSEcCtD
Isoprenaline—Hyperhidrosis—Triamcinolone—hematologic cancer	6.68e-05	0.000722	CcSEcCtD
Isoprenaline—Convulsion—Dexamethasone—hematologic cancer	6.66e-05	0.00072	CcSEcCtD
Isoprenaline—Convulsion—Betamethasone—hematologic cancer	6.66e-05	0.00072	CcSEcCtD
Isoprenaline—Headache—Thiotepa—hematologic cancer	6.64e-05	0.000718	CcSEcCtD
Isoprenaline—Hypertension—Betamethasone—hematologic cancer	6.63e-05	0.000717	CcSEcCtD
Isoprenaline—Hypertension—Dexamethasone—hematologic cancer	6.63e-05	0.000717	CcSEcCtD
Isoprenaline—Nausea—Vinorelbine—hematologic cancer	6.6e-05	0.000713	CcSEcCtD
Isoprenaline—Asthenia—Mitoxantrone—hematologic cancer	6.57e-05	0.00071	CcSEcCtD
Isoprenaline—Asthenia—Irinotecan—hematologic cancer	6.57e-05	0.00071	CcSEcCtD
Isoprenaline—Dizziness—Carmustine—hematologic cancer	6.51e-05	0.000704	CcSEcCtD
Isoprenaline—Dizziness—Alitretinoin—hematologic cancer	6.45e-05	0.000698	CcSEcCtD
Isoprenaline—Headache—Thalidomide—hematologic cancer	6.43e-05	0.000695	CcSEcCtD
Isoprenaline—Sweating—Epirubicin—hematologic cancer	6.42e-05	0.000694	CcSEcCtD
Isoprenaline—Asthenia—Gemcitabine—hematologic cancer	6.4e-05	0.000692	CcSEcCtD
Isoprenaline—Dizziness—Ifosfamide—hematologic cancer	6.38e-05	0.00069	CcSEcCtD
Isoprenaline—Vision blurred—Prednisone—hematologic cancer	6.3e-05	0.000682	CcSEcCtD
Isoprenaline—Nausea—Thiotepa—hematologic cancer	6.3e-05	0.000681	CcSEcCtD
Isoprenaline—Insomnia—Triamcinolone—hematologic cancer	6.25e-05	0.000676	CcSEcCtD
Isoprenaline—Dizziness—Vincristine—hematologic cancer	6.22e-05	0.000672	CcSEcCtD
Isoprenaline—Headache—Carmustine—hematologic cancer	6.17e-05	0.000667	CcSEcCtD
Isoprenaline—Dyspnoea—Triamcinolone—hematologic cancer	6.16e-05	0.000666	CcSEcCtD
Isoprenaline—Tachycardia—Betamethasone—hematologic cancer	6.12e-05	0.000661	CcSEcCtD
Isoprenaline—Tachycardia—Dexamethasone—hematologic cancer	6.12e-05	0.000661	CcSEcCtD
Isoprenaline—Headache—Alitretinoin—hematologic cancer	6.11e-05	0.000661	CcSEcCtD
Isoprenaline—Nausea—Thalidomide—hematologic cancer	6.09e-05	0.000659	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dexamethasone—hematologic cancer	6.06e-05	0.000655	CcSEcCtD
Isoprenaline—Hyperhidrosis—Betamethasone—hematologic cancer	6.06e-05	0.000655	CcSEcCtD
Isoprenaline—Dizziness—Irinotecan—hematologic cancer	6.06e-05	0.000655	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—hematologic cancer	6.01e-05	0.00065	CcSEcCtD
Isoprenaline—Asthenia—Cisplatin—hematologic cancer	5.97e-05	0.000645	CcSEcCtD
Isoprenaline—Sweating—Doxorubicin—hematologic cancer	5.94e-05	0.000642	CcSEcCtD
Isoprenaline—Headache—Vincristine—hematologic cancer	5.89e-05	0.000637	CcSEcCtD
Isoprenaline—Hypotension—Betamethasone—hematologic cancer	5.86e-05	0.000633	CcSEcCtD
Isoprenaline—Hypotension—Dexamethasone—hematologic cancer	5.86e-05	0.000633	CcSEcCtD
Isoprenaline—Nausea—Carmustine—hematologic cancer	5.85e-05	0.000633	CcSEcCtD
Isoprenaline—Nausea—Alitretinoin—hematologic cancer	5.8e-05	0.000627	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—hematologic cancer	5.8e-05	0.000627	CcSEcCtD
Isoprenaline—Hypertension—Prednisone—hematologic cancer	5.78e-05	0.000624	CcSEcCtD
Isoprenaline—Headache—Mitoxantrone—hematologic cancer	5.74e-05	0.00062	CcSEcCtD
Isoprenaline—Headache—Irinotecan—hematologic cancer	5.74e-05	0.00062	CcSEcCtD
Isoprenaline—Nausea—Ifosfamide—hematologic cancer	5.73e-05	0.000619	CcSEcCtD
Isoprenaline—Insomnia—Betamethasone—hematologic cancer	5.67e-05	0.000613	CcSEcCtD
Isoprenaline—Insomnia—Dexamethasone—hematologic cancer	5.67e-05	0.000613	CcSEcCtD
Isoprenaline—Headache—Gemcitabine—hematologic cancer	5.59e-05	0.000604	CcSEcCtD
Isoprenaline—Nausea—Vincristine—hematologic cancer	5.59e-05	0.000604	CcSEcCtD
Isoprenaline—Flushing—Epirubicin—hematologic cancer	5.58e-05	0.000603	CcSEcCtD
Isoprenaline—Asthenia—Etoposide—hematologic cancer	5.47e-05	0.000591	CcSEcCtD
Isoprenaline—Nausea—Mitoxantrone—hematologic cancer	5.44e-05	0.000588	CcSEcCtD
Isoprenaline—Nausea—Irinotecan—hematologic cancer	5.44e-05	0.000588	CcSEcCtD
Isoprenaline—Arrhythmia—Epirubicin—hematologic cancer	5.37e-05	0.00058	CcSEcCtD
Isoprenaline—Tachycardia—Prednisone—hematologic cancer	5.33e-05	0.000576	CcSEcCtD
Isoprenaline—Nausea—Gemcitabine—hematologic cancer	5.3e-05	0.000573	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—hematologic cancer	5.28e-05	0.000571	CcSEcCtD
Isoprenaline—Vision blurred—Methotrexate—hematologic cancer	5.27e-05	0.00057	CcSEcCtD
Isoprenaline—Flushing—Doxorubicin—hematologic cancer	5.16e-05	0.000558	CcSEcCtD
Isoprenaline—Tension—Epirubicin—hematologic cancer	5.13e-05	0.000555	CcSEcCtD
Isoprenaline—Nervousness—Epirubicin—hematologic cancer	5.08e-05	0.000549	CcSEcCtD
Isoprenaline—Dizziness—Etoposide—hematologic cancer	5.04e-05	0.000545	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—hematologic cancer	5.02e-05	0.000543	CcSEcCtD
Isoprenaline—Dizziness—Prednisolone—hematologic cancer	4.97e-05	0.000537	CcSEcCtD
Isoprenaline—Arrhythmia—Doxorubicin—hematologic cancer	4.97e-05	0.000537	CcSEcCtD
Isoprenaline—Asthenia—Triamcinolone—hematologic cancer	4.96e-05	0.000536	CcSEcCtD
Isoprenaline—Nausea—Cisplatin—hematologic cancer	4.94e-05	0.000534	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—hematologic cancer	4.94e-05	0.000534	CcSEcCtD
Isoprenaline—Vision blurred—Epirubicin—hematologic cancer	4.93e-05	0.000533	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—hematologic cancer	4.84e-05	0.000524	CcSEcCtD
Isoprenaline—Headache—Etoposide—hematologic cancer	4.77e-05	0.000516	CcSEcCtD
Isoprenaline—Tension—Doxorubicin—hematologic cancer	4.75e-05	0.000514	CcSEcCtD
Isoprenaline—Headache—Prednisolone—hematologic cancer	4.71e-05	0.000509	CcSEcCtD
Isoprenaline—Nervousness—Doxorubicin—hematologic cancer	4.7e-05	0.000508	CcSEcCtD
Isoprenaline—Vertigo—Epirubicin—hematologic cancer	4.7e-05	0.000508	CcSEcCtD
Isoprenaline—Palpitations—Epirubicin—hematologic cancer	4.62e-05	0.0005	CcSEcCtD
Isoprenaline—Dizziness—Triamcinolone—hematologic cancer	4.57e-05	0.000494	CcSEcCtD
Isoprenaline—Vision blurred—Doxorubicin—hematologic cancer	4.56e-05	0.000493	CcSEcCtD
Isoprenaline—Convulsion—Epirubicin—hematologic cancer	4.53e-05	0.00049	CcSEcCtD
Isoprenaline—Nausea—Etoposide—hematologic cancer	4.52e-05	0.000489	CcSEcCtD
Isoprenaline—Hypertension—Epirubicin—hematologic cancer	4.52e-05	0.000488	CcSEcCtD
Isoprenaline—Asthenia—Dexamethasone—hematologic cancer	4.5e-05	0.000486	CcSEcCtD
Isoprenaline—Asthenia—Betamethasone—hematologic cancer	4.5e-05	0.000486	CcSEcCtD
Isoprenaline—Nausea—Prednisolone—hematologic cancer	4.46e-05	0.000482	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methotrexate—hematologic cancer	4.41e-05	0.000477	CcSEcCtD
Isoprenaline—Vertigo—Doxorubicin—hematologic cancer	4.35e-05	0.00047	CcSEcCtD
Isoprenaline—Headache—Triamcinolone—hematologic cancer	4.33e-05	0.000468	CcSEcCtD
Isoprenaline—Palpitations—Doxorubicin—hematologic cancer	4.28e-05	0.000463	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—hematologic cancer	4.26e-05	0.000461	CcSEcCtD
Isoprenaline—Convulsion—Doxorubicin—hematologic cancer	4.19e-05	0.000453	CcSEcCtD
Isoprenaline—Hypertension—Doxorubicin—hematologic cancer	4.18e-05	0.000452	CcSEcCtD
Isoprenaline—Tachycardia—Epirubicin—hematologic cancer	4.17e-05	0.000451	CcSEcCtD
Isoprenaline—Dizziness—Dexamethasone—hematologic cancer	4.15e-05	0.000448	CcSEcCtD
Isoprenaline—Dizziness—Betamethasone—hematologic cancer	4.15e-05	0.000448	CcSEcCtD
Isoprenaline—Hyperhidrosis—Epirubicin—hematologic cancer	4.13e-05	0.000446	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—hematologic cancer	4.13e-05	0.000446	CcSEcCtD
Isoprenaline—Nausea—Triamcinolone—hematologic cancer	4.1e-05	0.000444	CcSEcCtD
Isoprenaline—Dyspnoea—Methotrexate—hematologic cancer	4.07e-05	0.00044	CcSEcCtD
Isoprenaline—Hypotension—Epirubicin—hematologic cancer	3.99e-05	0.000431	CcSEcCtD
Isoprenaline—Headache—Dexamethasone—hematologic cancer	3.93e-05	0.000425	CcSEcCtD
Isoprenaline—Headache—Betamethasone—hematologic cancer	3.93e-05	0.000425	CcSEcCtD
Isoprenaline—Asthenia—Prednisone—hematologic cancer	3.92e-05	0.000423	CcSEcCtD
Isoprenaline—Insomnia—Epirubicin—hematologic cancer	3.86e-05	0.000418	CcSEcCtD
Isoprenaline—Tachycardia—Doxorubicin—hematologic cancer	3.86e-05	0.000417	CcSEcCtD
Isoprenaline—Hyperhidrosis—Doxorubicin—hematologic cancer	3.82e-05	0.000413	CcSEcCtD
Isoprenaline—Dyspnoea—Epirubicin—hematologic cancer	3.81e-05	0.000412	CcSEcCtD
Isoprenaline—Nausea—Betamethasone—hematologic cancer	3.72e-05	0.000403	CcSEcCtD
Isoprenaline—Nausea—Dexamethasone—hematologic cancer	3.72e-05	0.000403	CcSEcCtD
Isoprenaline—Hypotension—Doxorubicin—hematologic cancer	3.69e-05	0.000399	CcSEcCtD
Isoprenaline—Dizziness—Prednisone—hematologic cancer	3.61e-05	0.00039	CcSEcCtD
Isoprenaline—Insomnia—Doxorubicin—hematologic cancer	3.57e-05	0.000386	CcSEcCtD
Isoprenaline—Dyspnoea—Doxorubicin—hematologic cancer	3.52e-05	0.000381	CcSEcCtD
Isoprenaline—Headache—Prednisone—hematologic cancer	3.42e-05	0.00037	CcSEcCtD
Isoprenaline—Asthenia—Methotrexate—hematologic cancer	3.27e-05	0.000354	CcSEcCtD
Isoprenaline—Nausea—Prednisone—hematologic cancer	3.24e-05	0.000351	CcSEcCtD
Isoprenaline—Asthenia—Epirubicin—hematologic cancer	3.06e-05	0.000331	CcSEcCtD
Isoprenaline—Dizziness—Methotrexate—hematologic cancer	3.02e-05	0.000326	CcSEcCtD
Isoprenaline—Headache—Methotrexate—hematologic cancer	2.86e-05	0.000309	CcSEcCtD
Isoprenaline—Asthenia—Doxorubicin—hematologic cancer	2.83e-05	0.000306	CcSEcCtD
Isoprenaline—Dizziness—Epirubicin—hematologic cancer	2.82e-05	0.000305	CcSEcCtD
Isoprenaline—Nausea—Methotrexate—hematologic cancer	2.71e-05	0.000293	CcSEcCtD
Isoprenaline—Headache—Epirubicin—hematologic cancer	2.67e-05	0.000289	CcSEcCtD
Isoprenaline—Dizziness—Doxorubicin—hematologic cancer	2.61e-05	0.000282	CcSEcCtD
Isoprenaline—Nausea—Epirubicin—hematologic cancer	2.54e-05	0.000274	CcSEcCtD
Isoprenaline—Headache—Doxorubicin—hematologic cancer	2.48e-05	0.000268	CcSEcCtD
Isoprenaline—Nausea—Doxorubicin—hematologic cancer	2.35e-05	0.000254	CcSEcCtD
Isoprenaline—CYP1A1—Metabolism—GSTP1—hematologic cancer	6.32e-07	3.42e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	6.28e-07	3.4e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TSC2—hematologic cancer	6.27e-07	3.4e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—MAPK3—hematologic cancer	6.23e-07	3.37e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CDKN1A—hematologic cancer	6.19e-07	3.35e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK8—hematologic cancer	6.19e-07	3.35e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CREB1—hematologic cancer	6.19e-07	3.35e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PTEN—hematologic cancer	6.18e-07	3.35e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—hematologic cancer	6.18e-07	3.34e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—SRC—hematologic cancer	6.17e-07	3.34e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CDKN1A—hematologic cancer	6.16e-07	3.34e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTEN—hematologic cancer	6.15e-07	3.33e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TSC2—hematologic cancer	6.14e-07	3.32e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—hematologic cancer	6.12e-07	3.32e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—hematologic cancer	6.12e-07	3.31e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.11e-07	3.31e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—BRAF—hematologic cancer	6.11e-07	3.31e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—hematologic cancer	6.05e-07	3.28e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK8—hematologic cancer	6.05e-07	3.27e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EP300—hematologic cancer	6.04e-07	3.27e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6R—hematologic cancer	6.04e-07	3.27e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	6.03e-07	3.27e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—hematologic cancer	6.03e-07	3.26e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CREBBP—hematologic cancer	6.03e-07	3.26e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—KRAS—hematologic cancer	6e-07	3.25e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCB1—hematologic cancer	5.98e-07	3.24e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	5.97e-07	3.23e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—STAT3—hematologic cancer	5.95e-07	3.22e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NRAS—hematologic cancer	5.94e-07	3.22e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—KRAS—hematologic cancer	5.91e-07	3.2e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	5.9e-07	3.2e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HRAS—hematologic cancer	5.9e-07	3.2e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EP300—hematologic cancer	5.89e-07	3.19e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SRC—hematologic cancer	5.87e-07	3.18e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EP300—hematologic cancer	5.86e-07	3.17e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ESR1—hematologic cancer	5.86e-07	3.17e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	5.84e-07	3.16e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTM1—hematologic cancer	5.81e-07	3.14e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NCOR1—hematologic cancer	5.81e-07	3.14e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FN1—hematologic cancer	5.79e-07	3.13e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAP2K1—hematologic cancer	5.75e-07	3.11e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ESR1—hematologic cancer	5.73e-07	3.1e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SRC—hematologic cancer	5.73e-07	3.1e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	5.72e-07	3.1e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—BAD—hematologic cancer	5.72e-07	3.1e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—hematologic cancer	5.72e-07	3.1e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CD—hematologic cancer	5.71e-07	3.09e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SRC—hematologic cancer	5.7e-07	3.09e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MAPK3—hematologic cancer	5.69e-07	3.08e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	5.67e-07	3.07e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—STAT3—hematologic cancer	5.66e-07	3.07e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FN1—hematologic cancer	5.66e-07	3.07e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—hematologic cancer	5.65e-07	3.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NRAS—hematologic cancer	5.65e-07	3.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—hematologic cancer	5.65e-07	3.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—hematologic cancer	5.64e-07	3.06e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—BAD—hematologic cancer	5.6e-07	3.03e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	5.6e-07	3.03e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—KRAS—hematologic cancer	5.59e-07	3.03e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—hematologic cancer	5.58e-07	3.02e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CD80—hematologic cancer	5.55e-07	3.01e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	5.54e-07	3e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	5.54e-07	3e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KIT—hematologic cancer	5.54e-07	3e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	5.54e-07	3e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—STAT3—hematologic cancer	5.53e-07	2.99e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NRAS—hematologic cancer	5.51e-07	2.99e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PIK3CA—hematologic cancer	5.51e-07	2.99e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—STAT3—hematologic cancer	5.5e-07	2.98e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NRAS—hematologic cancer	5.48e-07	2.97e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FGF2—hematologic cancer	5.47e-07	2.96e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	5.44e-07	2.95e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PIK3CA—hematologic cancer	5.43e-07	2.94e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CD80—hematologic cancer	5.43e-07	2.94e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	5.42e-07	2.93e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KIT—hematologic cancer	5.42e-07	2.93e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	5.42e-07	2.93e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK3—hematologic cancer	5.41e-07	2.93e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3R1—hematologic cancer	5.4e-07	2.92e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—hematologic cancer	5.39e-07	2.92e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PIK3CA—hematologic cancer	5.34e-07	2.89e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—hematologic cancer	5.33e-07	2.89e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	5.32e-07	2.88e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	5.31e-07	2.87e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK3—hematologic cancer	5.28e-07	2.86e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CREB1—hematologic cancer	5.27e-07	2.86e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MYC—hematologic cancer	5.26e-07	2.85e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—hematologic cancer	5.25e-07	2.84e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MAPK3—hematologic cancer	5.25e-07	2.84e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—hematologic cancer	5.25e-07	2.84e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JAK2—hematologic cancer	5.24e-07	2.84e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—hematologic cancer	5.21e-07	2.82e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—BRAF—hematologic cancer	5.21e-07	2.82e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	5.19e-07	2.81e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—hematologic cancer	5.16e-07	2.79e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CREB1—hematologic cancer	5.16e-07	2.79e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6R—hematologic cancer	5.14e-07	2.79e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—PIK3CA—hematologic cancer	5.14e-07	2.78e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	5.14e-07	2.78e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MYC—hematologic cancer	5.14e-07	2.78e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—hematologic cancer	5.13e-07	2.78e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—hematologic cancer	5.12e-07	2.77e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MDM2—hematologic cancer	5.12e-07	2.77e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—KRAS—hematologic cancer	5.11e-07	2.77e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MYC—hematologic cancer	5.11e-07	2.77e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HRAS—hematologic cancer	5.1e-07	2.76e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—hematologic cancer	5.1e-07	2.76e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—BRAF—hematologic cancer	5.09e-07	2.76e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—hematologic cancer	5.05e-07	2.73e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6R—hematologic cancer	5.03e-07	2.72e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	5.02e-07	2.72e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HRAS—hematologic cancer	5.02e-07	2.72e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MTOR—hematologic cancer	4.98e-07	2.7e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CB—hematologic cancer	4.98e-07	2.7e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	4.9e-07	2.65e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—hematologic cancer	4.88e-07	2.64e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	4.87e-07	2.64e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KRAS—hematologic cancer	4.86e-07	2.63e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.82e-07	2.61e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—hematologic cancer	4.81e-07	2.6e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	4.8e-07	2.6e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	4.77e-07	2.58e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	4.76e-07	2.58e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HRAS—hematologic cancer	4.76e-07	2.57e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KRAS—hematologic cancer	4.75e-07	2.57e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—KRAS—hematologic cancer	4.72e-07	2.56e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	4.72e-07	2.56e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—PIK3CA—hematologic cancer	4.7e-07	2.54e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDKN1B—hematologic cancer	4.67e-07	2.53e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	4.66e-07	2.53e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FGF2—hematologic cancer	4.66e-07	2.52e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	4.6e-07	2.49e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—hematologic cancer	4.58e-07	2.48e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2—hematologic cancer	4.57e-07	2.48e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FGF2—hematologic cancer	4.56e-07	2.47e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—hematologic cancer	4.55e-07	2.46e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.52e-07	2.45e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—hematologic cancer	4.5e-07	2.44e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	4.5e-07	2.44e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JAK2—hematologic cancer	4.47e-07	2.42e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PIK3CA—hematologic cancer	4.47e-07	2.42e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCND1—hematologic cancer	4.46e-07	2.41e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JUN—hematologic cancer	4.45e-07	2.41e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—hematologic cancer	4.44e-07	2.4e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	4.38e-07	2.37e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JAK2—hematologic cancer	4.37e-07	2.37e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—hematologic cancer	4.36e-07	2.36e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MDM2—hematologic cancer	4.36e-07	2.36e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PIK3CA—hematologic cancer	4.36e-07	2.36e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HRAS—hematologic cancer	4.35e-07	2.35e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PIK3CA—hematologic cancer	4.34e-07	2.35e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—hematologic cancer	4.32e-07	2.34e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDKN1A—hematologic cancer	4.31e-07	2.34e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CG—hematologic cancer	4.31e-07	2.33e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PTEN—hematologic cancer	4.3e-07	2.33e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	4.29e-07	2.32e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MDM2—hematologic cancer	4.27e-07	2.31e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	4.25e-07	2.3e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MTOR—hematologic cancer	4.25e-07	2.3e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—hematologic cancer	4.22e-07	2.28e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK8—hematologic cancer	4.21e-07	2.28e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—hematologic cancer	4.2e-07	2.27e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—hematologic cancer	4.16e-07	2.25e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MTOR—hematologic cancer	4.15e-07	2.25e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	4.15e-07	2.25e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HRAS—hematologic cancer	4.13e-07	2.24e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EP300—hematologic cancer	4.1e-07	2.22e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	4.05e-07	2.19e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HRAS—hematologic cancer	4.03e-07	2.18e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HRAS—hematologic cancer	4.01e-07	2.17e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CREBBP—hematologic cancer	4e-07	2.16e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SRC—hematologic cancer	3.99e-07	2.16e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	3.98e-07	2.16e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	3.96e-07	2.15e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—hematologic cancer	3.96e-07	2.14e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	3.94e-07	2.13e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—hematologic cancer	3.9e-07	2.11e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2—hematologic cancer	3.9e-07	2.11e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	3.9e-07	2.11e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—hematologic cancer	3.89e-07	2.1e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—hematologic cancer	3.88e-07	2.1e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—hematologic cancer	3.86e-07	2.09e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	3.85e-07	2.09e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT3—hematologic cancer	3.85e-07	2.08e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NRAS—hematologic cancer	3.84e-07	2.08e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—hematologic cancer	3.84e-07	2.08e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—hematologic cancer	3.84e-07	2.08e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—hematologic cancer	3.82e-07	2.07e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2—hematologic cancer	3.81e-07	2.06e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCND1—hematologic cancer	3.8e-07	2.06e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—hematologic cancer	3.79e-07	2.05e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JUN—hematologic cancer	3.79e-07	2.05e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CD—hematologic cancer	3.79e-07	2.05e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—hematologic cancer	3.74e-07	2.03e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCND1—hematologic cancer	3.72e-07	2.01e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JUN—hematologic cancer	3.71e-07	2.01e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK3—hematologic cancer	3.68e-07	1.99e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	3.68e-07	1.99e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PTEN—hematologic cancer	3.67e-07	1.99e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—hematologic cancer	3.65e-07	1.98e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	3.6e-07	1.95e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	3.59e-07	1.94e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTEN—hematologic cancer	3.59e-07	1.94e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3R1—hematologic cancer	3.58e-07	1.94e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	3.58e-07	1.94e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MYC—hematologic cancer	3.58e-07	1.94e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—hematologic cancer	3.57e-07	1.93e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—hematologic cancer	3.56e-07	1.93e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—hematologic cancer	3.54e-07	1.92e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	3.51e-07	1.9e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	3.5e-07	1.9e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EP300—hematologic cancer	3.5e-07	1.89e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EP300—hematologic cancer	3.42e-07	1.85e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SRC—hematologic cancer	3.4e-07	1.84e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SRC—hematologic cancer	3.33e-07	1.8e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	3.31e-07	1.79e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KRAS—hematologic cancer	3.31e-07	1.79e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CB—hematologic cancer	3.3e-07	1.79e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT3—hematologic cancer	3.28e-07	1.78e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NRAS—hematologic cancer	3.27e-07	1.77e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	3.24e-07	1.75e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT3—hematologic cancer	3.21e-07	1.74e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NRAS—hematologic cancer	3.2e-07	1.73e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	3.13e-07	1.7e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	3.07e-07	1.66e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MYC—hematologic cancer	3.05e-07	1.65e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	3.04e-07	1.65e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CA—hematologic cancer	3.04e-07	1.64e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MYC—hematologic cancer	2.98e-07	1.61e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	2.97e-07	1.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—hematologic cancer	2.94e-07	1.59e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTEN—hematologic cancer	2.86e-07	1.55e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KRAS—hematologic cancer	2.82e-07	1.53e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HRAS—hematologic cancer	2.81e-07	1.52e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KRAS—hematologic cancer	2.76e-07	1.49e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—EP300—hematologic cancer	2.72e-07	1.47e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—hematologic cancer	2.69e-07	1.46e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	2.59e-07	1.4e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	2.53e-07	1.37e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—hematologic cancer	2.5e-07	1.36e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—hematologic cancer	2.48e-07	1.34e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—hematologic cancer	2.45e-07	1.33e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HRAS—hematologic cancer	2.39e-07	1.3e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HRAS—hematologic cancer	2.34e-07	1.27e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—hematologic cancer	2.29e-07	1.24e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—hematologic cancer	2.24e-07	1.21e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—hematologic cancer	2.11e-07	1.14e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—hematologic cancer	2.07e-07	1.12e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CA—hematologic cancer	2.01e-07	1.09e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—hematologic cancer	1.65e-07	8.91e-07	CbGpPWpGaD
